Brief: Zymeworks Said To Near $929 Million Deal For Theravance - Bloomberg News
29/06/2026 10:23
BRIEF-Zymeworks Said To Near $929 Million Deal For Theravance - Bloomberg News June 29 (Reuters) -
ZYMEWORKS SAID TO NEAR $929 MILLION DEAL FOR THERAVANCE - BLOOMBERG NEWS
ZYMEWORKS IS DISCUSSING PAYING $17 PER SHARE FOR THERAVANCE- BLOOMBERG NEWS
Source https://tinyurl.com/363926nk
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Theravance Biopharma
See all newsTheravance Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ireland's Theravance Biopharma Q2 revenue rises 11% but misses estimates
Brief: Theravance Biopharma Q2 Operating Income USD -8.277 Million
Press Digest: Canada - June 30
Deals of the day-Mergers and acquisitions